Skip to main content

Biometry

Contributes to the rigor and reproducibility of cancer research through statistical consultation and mathematical modeling. Supports research in biostatistical methods and data analytics, machine learning, and artificial intelligence for cancer risk prediction and reduction.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Resources

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Berger, Vance, Ph.D. vance.berger@nih.gov 240-276-7142	5E628	Statistician \| Biometry
	Bowles, Heather, Ph.D. heather.bowles@nih.gov 240-276-6794	5E640	Program Officer \| Biometry Cancer Prevention Fellowship Program
	Dodd, Kevin, Ph.D. kevin_dodd@nih.gov 240-276-7021	5E126	Deputy Chief \| Biometry
	Hu, Ping, Sc.D. ping.hu@nih.gov 240-276-7015	5E118	Statistician \| Biometry
	Morris, Lawrence lawrence.morris@nih.gov 240-276-7137	5E112	Program Specialist \| Biometry
	Prorok, Philip C, Ph.D. [C] philip.prorok@nih.gov 240-276-7131		Contractor \| Office of the Director Biometry
	Sirota, Lev, Ph.D. [C] lev.sirota@nih.gov 240-276-5127	5E114	Contractor \| Biometry
	Uzzell, Norwood norwood.uzzell@nih.gov 240-276-7141	5E222	Program Support Assistant \| Biometry
	Xu, Jian-Lun, Ph.D. jian-lun.xu@nih.gov 240-276-7023	5E128	Statistician \| Biometry

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Perkins, Susan M	Indiana University Indianapolis United States	Evaluation of the Communication Plan Early through End-of-Life (COMPLETE) Intervention	5R01CA235632-06	Brennan Streck, Ph.D., RN, M.P.H.
Permuth, Jennifer B	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-07	Matthew Young, Ph.D.
Pfleger, Cathie M	Icahn School Of Medicine At Mount Sinai United States	A Drosophila model for Aromatase Inhibitor-induced Musculoskeletal Pain	1R21CA303409-01	Rachel Altshuler, Ph.D.
Phillips, Nicholas S	St. Jude Children'S Research Hospital United States	Cardiopulmonary function and cerebral blood flow in Hodgkin Lymphoma survivors	5R21CA280230-02	Eileen Dimond, R.N., M.S.
Pinder, Leeya F	University Of Cincinnati United States	RepurPosed AntiretrOviraL ThErapieS to EliminAte Cervical Cancer (POLESA Trial)	3R37CA284033-03S1	Vikrant Sahasrabuddhe, M.B.B.S., M.P.H., Dr.P.H.
Pistilli, Emidio Edward	West Virginia University United States	Targeting Muscle Fatigability During Cachexia	5R01AR079445-04	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Pitteri, Sharon	Stanford University United States	Glycosylation and Immune Evasion in Urologic Tumors	5U01CA226051-05
Plas, Ellen Van Der	Arkansas Children'S Hospital Res Inst United States	Identifying markers of abnormal neurocognitive trajectories during chemotherapy treatment of childhood acute lymphoblastic leukemia	5R37CA266135-04	Asad Umar, D.V.M., Ph.D.
Porter, Laura S	Duke University United States	Couple Communication Skills Training for Advanced Cancer	5R01CA229425-05	Brennan Streck, Ph.D., RN, M.P.H.
Pozdeyev, Nikita	University Of Colorado Denver United States	Genetic architecture of thyroid cancer and its clinical utility	5R21CA282380-02	Wendy Wang, Ph.D., M.Sc.
Prigerson, Holly Gwen	Weill Medical Coll Of Cornell Univ United States	Behavioral and Psychosocial Effects on Study Outcomes in End-Stage Cancer Treatment (BEST End-Stage Cancer Study)	5R35CA197730-11	Brennan Streck, Ph.D., RN, M.P.H.
Punnen, Sanoj	University Of Miami School Of Medicine United States	The Rigor and Clinical Utility of PSMA Enriched Extracellular Vesicles for Prostate Cancer Detection	5R01CA272766-03	Matthew Young, Ph.D.
Pyter, Leah M	Ohio State University United States	Chemotherapy-induced circadian master clock disruptions and fatigue	3R01CA270372-03S1	Marjorie Perloff, M.D.
Rajagopalan, Malolan S	Columbus Community Clinical Oncology Prg United States	Columbus NCORP RFA-CA-18-016	3UG1CA189954-11S1	Vanessa A. White, M.P.H.
Rajkumar, S Vincent	Mayo Clinic Rochester United States	Onset and biomarkers for progression of monoclonal gammopathies	5R01CA168762-11	Nicholas Hodges, Ph.D.